Imbrave150 Updated Data On Atezo Plus Bev Versus Sorafenib In Hcc

Summary

Peter R. Galle, MD, PhD, Johannes Gutenberg University, Mainz, Germany, shares Daneng Li, MD, of City of Hope National Medical Center, Duarte, CA, discusses results from older adults enrolled in First-line treatment options for advanced Dr. Finn, Professor, Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, Director, Signal ... Pierce Chow, MBBS, MMed (Surg), FRCS (Edin), FAMS (Gen Surg), PhD, National Cancer Centre Singapore & Duke-NUS ... ... more exciting was the durability of the responses so the Daneng Li, MD, discusses the subgroup analysis of the phase 3 Prof Pierce Chow speaks to ecancer as part of AACR 2023 about the phase III IMbrave050 trial of atezolizumab Masatoshi Kudo, MD, PhD, Department of Gastroenterology and Hepatology, Kindai University, discusses what he thinks the ... Website: onclive.com Twitter: twitter.com/OncLive Facebook: facebook.com/OncLive/ LinkedIn: ...